Neurovascular Devices Market, By Device Type, By Therapeutic Application, By End User, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Aug 2023

Code : CMI4224

Pages :212

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Neurovascular Devices Market: Key Developments

On June 28, 2023, Boston Scientific Corporation, a medical device company, announced it has received U.S. FDA 510(k) clearance for the Embold Soft and Packing coils, which are designed for use in a variety of embolization procedures.
On June 20, 2023, Sensome, a smart medical device company, announced collaboration with Asahi Intecc, a Japan-based medical device company, to develop the next generation Clotild Smart Guidewire, for the treatment of acute ischemic stroke. This treatment involves the removal of a clot obstructing a blood vessel in the brain using a thrombectomy device guided over a wire from the wrist or groin to the site of the blockage.
On March 14, 2023, Scientia Vascular, a leader and pioneer in differentiated neurovascular access technology, announces U.S. FDA 510k clearance of the Aristotle Colossus macrowire. Aristotle Colossus utilizes breakthrough microfabrication design technology. This advancement in manufacturing allows for a soft, atraumatic tip and is designed to support the tracking of large bore catheters to the treatment site and drive superior navigability of distal, tortuous anatomy.
In April 2022, Boston Scientific Corporation, a medical device company, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature.